02 Oct 2022

October, Breast Cancer Awareness Month

It’s October, which means it’s Breast Cancer Awareness month. This journey starts with accurate diagnosis: and that is where MammaTyper® comes in.

11 Jul 2022

Ki-67; Love it or Hate it?

Ki-67 is a great aid in the diagnosis and treatment of a variety of cancers. If you are a patient looking for more information, you might find this article a bit technical, but you can still head on over to cercabiotech.com for our patient-focussed information which we hope can help.

19 May 2022

World Pre Eclampsia Day (May 22nd)

Early diagnosis of Pre-Eclampsia can save lives. Yet, definitive detection of this potentially fatal condition can be delayed or difficult to access under current testing regimes. To help combat this issue, Cerca Biotech is launching a new, rapid point-of-care test designed for use in maternity departments and primary care settings. 

31 Mar 2022

MammaTyper® announces registration in Italy

We are really pleased to announce that MammaTyper® has been registered by the Ministero della Salute in Italy. This marks a key step towards bringing this innovative, RT-qPCR test to the Italian market and helping women who have been diagnosed with breast cancer. This announcement follows our earlier news that Padua-based firm AB Analytica will be the exclusive distributor for MammaTyper® in Italy.

08 Mar 2022

March 8th - International Women’s Day

International Women’s Day is a time to celebrate the social, economic, cultural and political achievements of women everywhere. This year, the focus is on how to #breakthebias that women see in many aspects of their lives.

22 Feb 2022

New Distribution Agreements

We are really pleased to announce that we have signed exclusive distribution agreements with four key European partners in the last month.

02 Feb 2022

February 4th - World Cancer Day

February 4th is World Cancer Day. Events are taking place around the globe to raise awareness of the hundreds of different forms cancer can take and how we all need to pull together to #closethegap in treatment options no matter where you live.